Tag diabetes care

The federal health agency recently authorized the first generic version of semaglutide. This decision marks the initial regulatory approval for a lower-cost alternative. A major pharmaceutical manufacturer submitted the product for regulatory review earlier this year. Furthermore, the agency completed…